Evidence map›Paper›PMID 42273522›Full record

ArticleCancer communications (London, England)2026

Allan M Johansen, Julie T Ziegler, Kojo Agyemang, Michael J Pennison, Hugo Jimenez, Loïc Le Marchand, John L Hopper, Daniel D Buchanan, Antonio Di Cristofano, Wencheng Li and 9 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer communications (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Allan M JohansenDepartment of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC, USA.ORCID https://orcid.org/0000-0002-2896-1749
Julie T ZieglerDepartment of Biostatistics and Data Science, Division of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
Kojo AgyemangDepartment of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Michael J PennisonDepartment of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Hugo JimenezDepartment of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA.
Loïc Le MarchandEpidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA.
John L HopperCentre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
Daniel D BuchananColorectal Oncogenomics Group, Department of Clinical Pathology, The University of Melbourne, Parkville, Victoria, Australia.
Antonio Di CristofanoDepartment of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, NY, USA.
Wencheng LiDepartment of Pathology, Wake Forest University Baptist Medical Center, Winston-Salem, NC, USA.
Greg DysonDepartment of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA.
Ann G SchwartzDepartment of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA.
Jennifer L Beebe-DimmerDepartment of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA.
Lara Sucheston-CampbellDepartment of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA.
Asfar S AzmiDepartment of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA.
Wael SakrDepartment of Pathology, Wayne State University, Detroit, MI, USA.
Ralph B D'AgostinoDepartment of Biostatistics and Data Science, Division of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
Carl D LangefeldDepartment of Biostatistics and Data Science, Division of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
Boris C PascheDepartment of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA.

Funding

Data sharing: the Colon Cancer Family Registry CohortU01CA167551 · NCI · UNIVERSITY OF MELBOURNE · PI Daniel David BUCHANAN, Steven Gallinger · 2018 to 2026
$16.8M
Transdisciplinary Studies of Genetic Variation in Colorectal CancerU19CA148107 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI GRUBER, STEPHEN B · 2010 to 2014
$11.1M
MOLECULAR EPIDEMIOLOGY OF COLORECTAL CANCERR01CA081488 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GRUBER, STEPHEN B · 1999 to 2008
$9.2M
Genomic Wide Association Study of Colorectal CancerU01CA122839 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI CASEY, GRAHAM · 2006 to 2010
$7.3M
Hormones and Colon Cancer: Epigenetic Subtypes, Risk, and SurvivalR01CA076366 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI NEWCOMB, POLLY A · 1998 to 2009
$2.4M
TGFBR1 Signaling in Colorectal CancerR01CA137000 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI PASCHE, BORIS · 2010 to 2014
$1.5M
TGF-beta pathway polymorphisms and colon cancer riskR01CA108741 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI PASCHE, BORIS · 2006 to 2008
$804k
NCI NIH HHS R01 CA076366NCI NIH HHS R01 CA081488NCI NIH HHS R01 CA108741NCI NIH HHS R01 CA137000NCI NIH HHS U01 CA122839NCI NIH HHS U01 CA167551NCI NIH HHS U19 CA148107NHLBI NIH HHS HHSN268201200008CNHLBI NIH HHS HHSN268201200008I
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42273522
PMCPMC13247310

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.